Data / Form D filings / Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc.: Form D filings
Alliqua BioMedical, Inc., a biotechnology company in Yardley, PA, filed 19 Form D notices with the SEC between 2010 and 2017. The latest, on March 13, 2017, reports $2.8 million sold of a $2.9 million offering to 8 investors.
Find out what Alliqua BioMedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1010 STONY HILL ROAD, SUITE 200, Yardley, PA, 19067
- Phone
- (215) 702-8550
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1054274
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2017 | New notice | $2,900,000 | $2,770,000 | $130,000 | 8 | Feb 27, 2017 | sec.gov |
| May 15, 2014 | New notice | $7,003,080 | $2,003,080 | $5,000,000 | 43 | May 5, 2014 | sec.gov |
| Apr 28, 2014 | New notice | $14,975,000 | $14,975,000 | $0 | 18 | Apr 14, 2014 | sec.gov |
| Nov 25, 2013 | New notice | $7,000,000 | $7,000,000 | $0 | 12 | Nov 18, 2013 | sec.gov |
| Nov 25, 2013 | New notice | $6,000,000 | $6,000,000 | $0 | 1 | Nov 14, 2013 | sec.gov |
| Nov 25, 2013 | New notice | $651,578 | $651,578 | $0 | 1 | Nov 11, 2013 | sec.gov |
| Nov 18, 2013 | Amendment | $1,000,000 | $1,000,000 | $0 | 1 | Oct 22, 2013 | sec.gov |
| Nov 6, 2013 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Oct 22, 2013 | sec.gov |
| Jul 9, 2013 | New notice | $2,000,000 | $1,976,925 | $23,075 | 30 | Jun 28, 2013 | sec.gov |
| Jun 10, 2013 | Amendment | $3,000,000 | $1,100,000 | $1,900,000 | 26 | Apr 11, 2013 | sec.gov |
| May 7, 2013 | Amendment | $3,000,000 | $812,000 | $2,188,000 | 19 | Apr 11, 2013 | sec.gov |
| Apr 24, 2013 | Amendment | $3,000,000 | $702,000 | $2,298,000 | 17 | Apr 11, 2013 | sec.gov |
| Apr 18, 2013 | New notice | $3,000,000 | $236,000 | $2,764,000 | 8 | Apr 11, 2013 | sec.gov |
| Nov 15, 2012 | New notice | $815,000 | $815,000 | $0 | 10 | Nov 8, 2012 | sec.gov |
| Aug 29, 2012 | New notice | $295,000 | $265,000 | $30,000 | 4 | Aug 14, 2012 | sec.gov |
| Mar 1, 2012 | New notice | $1,050,000 | $1,050,000 | $0 | 12 | Feb 16, 2012 | sec.gov |
| Mar 17, 2011 | New notice | $1,000,000 | $1,000,000 | $0 | 1 | Mar 2, 2011 | sec.gov |
| May 25, 2010 | New notice | $10,600,000 | $10,600,000 | $0 | 17 | May 11, 2010 | sec.gov |
| May 25, 2010 | New notice | $2,500,000 | $1,425,000 | $1,075,000 | 15 | May 11, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Posner | Executive Officer | |
| Jerome Zeldis | Director | |
| David Johnson | Executive Officer, Director | |
| Pellegrino Pionati | Executive Officer | |
| Joseph Leone | Director | |
| Gary Restani | Director | |
| Jeffrey Sklar | Director | |
| Brad Barton | Executive Officer | |
| Winston Kung | Director | |
| Mark Wagner | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Mar 13, 2017 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alliqua BioMedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.